SCHEMBL20426692

SCHEMBL20426692

c1ccc2c(c1)[nH]c1ccc3occc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 2/20 0.49
▸ GABRD O14764 2/20 0.49
▸ GABRA1 P14867 2/20 0.49
▸ GABRB1 P18505 2/20 0.49
▸ GABRG2 P18507 2/20 0.49
▸ GABRB3 P28472 2/20 0.49
▸ GABRA5 P31644 2/20 0.49
▸ GABRA3 P34903 2/20 0.49
▸ GABRA2 P47869 2/20 0.49
▸ GABRB2 P47870 2/20 0.49
▸ GABRA4 P48169 2/20 0.49
▸ GABRE P78334 2/20 0.49
▸ GABRA6 Q16445 2/20 0.49
▸ GABRG1 Q8N1C3 2/20 0.49
▸ GABRG3 Q99928 2/20 0.49
▸ GABRQ Q9UN88 2/20 0.49
▸ CDK4 P11802 2/20 0.46
▸ CCND1 P24385 2/20 0.46
▸ IMPDH2 P12268 1/20 0.46
▸ IMPDH1 P20839 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414540 0.77 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29819495 0.76 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17948240 0.76 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29641937 0.76 GABRP (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12219442 0.76 GABRP (0.69) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29380761 0.76 ALDH1A1 (0.68) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1635466 0.76 ALDH1A1 (0.68) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30560782 0.75 KIF11 (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2050391 0.75 KIF11 (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12240744 0.74 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU GABRP 2272/4885GABRD 3979/4885GABRA1 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback